Latest filings (excl ownership)
S-3
Shelf registration
26 Apr 24
10-K/A
2023 FY
Annual report (amended)
25 Apr 24
EFFECT
Notice of effectiveness
17 Apr 24
424B3
Prospectus supplement
16 Apr 24
D
$2.46 mm in equity / options / securities to be acquired, sold $1.24 mm, 3 investors
12 Apr 24
D
$3.50 mm in equity / options / securities to be acquired, sold $1.75 mm, 1 investor
12 Apr 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12 Apr 24
D
$1.47 mm in options / securities to be acquired, 4 investors
12 Apr 24
ARS
2023 FY
Annual report to shareholders
2 Apr 24
DEF 14A
Definitive proxy
2 Apr 24
S-3
Shelf registration
2 Apr 24
10-K
2023 FY
Annual report
1 Apr 24
NT 10-K
Notice of late annual filing
1 Apr 24
8-K
Entry into a Material Definitive Agreement
1 Apr 24
8-K
Other Events
28 Mar 24
424B5
Prospectus supplement for primary offering
28 Mar 24
8-K
Other Events
27 Mar 24
8-K
Departure of Directors or Certain Officers
4 Mar 24
8-K
Vaccinex Announces Multiple New Agreements for Access to ActivMAb® Antigen Virus Technology
21 Feb 24
8-K
Vaccinex, Inc. Announces Reverse Stock Split
15 Feb 24
8-K
Submission of Matters to a Vote of Security Holders
13 Feb 24
8-K/A
Financial Statements and Exhibits
8 Feb 24
8-K
Entry into a Material Definitive Agreement
7 Feb 24
EFFECT
Notice of effectiveness
22 Jan 24
424B3
Prospectus supplement
19 Jan 24
CORRESP
Correspondence with SEC
17 Jan 24
UPLOAD
Letter from SEC
16 Jan 24
S-3
Shelf registration
10 Jan 24
DEF 14A
Definitive proxy
8 Jan 24
PRE 14A
Preliminary proxy
28 Dec 23
10-Q
2023 Q3
Quarterly report
13 Nov 23
8-K
Vaccinex Reports Positive Effect of Pepinemab Treatment on New Biomarker of Brain Inflammation
26 Oct 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
13 Oct 23
8-K
Entry into a Material Definitive Agreement
4 Oct 23
424B4
Prospectus supplement with pricing info
2 Oct 23
EFFECT
Notice of effectiveness
29 Sep 23
S-1MEF
Registration of additional securities for an S-1
28 Sep 23
8-K
Regulation FD Disclosure
27 Sep 23
8-K
Regulation FD Disclosure
26 Sep 23
S-1/A
IPO registration (amended)
26 Sep 23
Latest ownership filings
4
ALBERT FRIEDBERG
22 Apr 24
4
Maurice Zauderer
1 Apr 24
4
ALBERT FRIEDBERG
1 Apr 24
4
Elizabeth E. Evans
22 Mar 24
4
Ernest S. Smith
22 Mar 24
4
Jill Sanchez
22 Mar 24
4
Maurice Zauderer
22 Mar 24
3
Jill Sanchez
14 Mar 24
SC 13D/A
FCMI Parent Co.
13 Feb 24
SC 13D/A
Zauderer Maurice
12 Feb 24
4
Maurice Zauderer
9 Feb 24
4
ALBERT FRIEDBERG
9 Feb 24
SC 13G
Point72 Asset Management, L.P.
9 Feb 24
SC 13G/A
HIRSCHMAN ORIN
7 Feb 24
4
Strydonck, Gerald E. Van
28 Dec 23
4
Strydonck, Gerald E. Van
12 Dec 23
4
Maurice Zauderer
3 Nov 23
4
Jacob B. Frieberg
25 Oct 23
SC 13D/A
FCMI Parent Co.
18 Oct 23
SC 13D/A
Zauderer Maurice
12 Oct 23
SC 13G
HIRSCHMAN ORIN
11 Oct 23
4
Maurice Zauderer
5 Oct 23
4
ALBERT FRIEDBERG
5 Oct 23
4
Jacob B. Frieberg
5 Oct 23
SC 13D/A
Zauderer Maurice
26 Sep 23
4
Maurice Zauderer
25 Sep 23
SC 13D/A
FCMI Parent Co.
25 May 23
4
ALBERT FRIEDBERG
16 May 23
4
Chrystyna Bedrij Stecyk
15 May 23
4
Jacob B. Frieberg
15 May 23
4
BALA S MANIAN
15 May 23
4
Barbara Yanni
15 May 23
4
Strydonck, Gerald E. Van
15 May 23
SC 13D/A
FCMI Parent Co.
5 Apr 23
4
John E. Leonard
3 Apr 23
4
Elizabeth E. Evans
3 Apr 23
4
Jacob B. Frieberg
3 Apr 23
4
ALBERT FRIEDBERG
3 Apr 23
4
Ernest S. Smith
3 Apr 23
4
Scott E. Royer
3 Apr 23